Skip to content

APOTHEEK CLAEYS-BUYLE: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

APOTHEEK CLAEYS-BUYLE

BE 0878.090.916
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€100,792
2024 · €72,056+€28,736
Equity
€748,243
2024 · €700,420+€47,824
Cash
€563,029
2024 · €483,496+€79,532
Balance sheet total
€1.3m
2024 · €1.1m+€126,688

Largest movements

2024 to 2025
Assets
  • Current investments +€102,709

    up €102,709 (+77.7%), from €132,151 to €234,860

  • Cash +€79,532

    up €79,532 (+16.4%), from €483,496 to €563,029

    mainly Net result for the year (+€100,792) and Stocks and contracts (+€54,793)

  • Stocks and contracts -€54,793

    down €54,793 (-20.1%), from €272,128 to €217,335

  • Tangible fixed assets -€27,007

    down €27,007 (-34.9%), from €77,461 to €50,454

    of which Land and buildings: -€37,749

  • Receivables within one year +€26,232

    up €26,232 (+19.2%), from €136,798 to €163,031

    of which Trade receivables: +€26,236

Equity and liabilities
  • Other debts +€50,497

    up €50,497 (+70.8%), from €71,296 to €121,793

  • Reserves +€47,824

    up €47,824 (+7.0%), from €681,820 to €729,643

    of which Distributable reserves: +€47,824

  • Trade debts +€15,542

    up €15,542 (+4.9%), from €318,966 to €334,507

Income statement
  • Gross operating margin +€43,885

    up €43,885 (+11.1%), from €396,951 to €440,836

  • Taxes +€12,368

    up €12,368 (+39.5%), from €31,351 to €43,719

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €72,056
Gross operating margin +€43,885
Staff costs -€3,967
Depreciation +€3,846
Other operating charges +€47
Financial income +€854
Financial charges -€3,562
Taxes -€12,368
Result 2025 €100,792
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€249,178
Investment -€116,678
Financing -€52,968
Cash 2024 €483,496
Net result for the year +€100,792
Depreciation +€40,976
Stocks and contracts +€54,793
Receivables within one year -€26,232
Deferred charges and accrued income -€14
Trade debts +€15,542
Tax, wage and social debts +€10,361
Other debts +€50,497
Accrued charges and deferred income +€2,465
Investment in fixed assets (net) -€13,969
Current investments -€102,709
Contributions, distributions and other -€52,968
Cash 2025 €563,029
brings cash intakes cash out
Every line side by side 44 lines
Line Code 2024 2025 Change %
Total assets 20/58 €1,143,815 €1,270,503 +€126,688 +11.1%
Fixed assets 21/28 €77,791 €50,785 -€27,007 -34.7%
Tangible fixed assets 22/27 €77,461 €50,454 -€27,007 -34.9%
Land and buildings 22 €50,538 €12,790 -€37,749 -74.7%
Plant, machinery and equipment 23 €2,883 €16,004 +€13,121 +455%
Furniture and vehicles 24 €24,039 €21,660 -€2,379 -9.9%
Financial fixed assets 28 €331 €331 = 0.0%
Current assets 29/58 €1,066,024 €1,219,719 +€153,695 +14.4%
Stocks and contracts in progress 3 €272,128 €217,335 -€54,793 -20.1%
Stocks 30/36 €272,128 €217,335 -€54,793 -20.1%
Amounts receivable within one year 40/41 €136,798 €163,031 +€26,232 +19.2%
Trade receivables 40 €136,795 €163,031 +€26,236 +19.2%
Other amounts receivable 41 €4 - -€4
Current investments 50/53 €132,151 €234,860 +€102,709 +77.7%
Cash at bank and in hand 54/58 €483,496 €563,029 +€79,532 +16.4%
Deferred charges and accrued income 490/1 €41,450 €41,464 +€14 0.0%
Total equity and liabilities 10/49 €1,143,815 €1,270,503 +€126,688 +11.1%
Equity 10/15 €700,420 €748,243 +€47,824 +6.8%
Contributions 10/11 €18,600 €18,600 = 0.0%
Reserves 13 €681,820 €729,643 +€47,824 +7.0%
Tax-exempt reserves 132 €3,307 €3,307 = 0.0%
Distributable reserves 133 €678,513 €726,336 +€47,824 +7.0%
Amounts payable 17/49 €443,396 €522,260 +€78,864 +17.8%
Amounts payable within one year 42/48 €440,045 €516,445 +€76,400 +17.4%
Trade debts 44 €318,966 €334,507 +€15,542 +4.9%
Suppliers 440/4 €318,966 €334,507 +€15,542 +4.9%
Taxes, remuneration and social security 45 €49,784 €60,145 +€10,361 +20.8%
Taxes 450/3 €9,879 €21,617 +€11,738 +119%
Remuneration and social security 454/9 €39,905 €38,528 -€1,378 -3.5%
Other amounts payable 47/48 €71,296 €121,793 +€50,497 +70.8%
Accrued charges and deferred income 492/3 €3,350 €5,815 +€2,465 +73.6%
Remuneration, social security and pensions 62 €245,049 €249,016 +€3,967 +1.6%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €44,822 €40,976 -€3,846 -8.6%
Other operating charges 640/8 €2,701 €2,654 -€47 -1.7%
Gross operating margin 9900 €396,951 €440,836 +€43,885 +11.1%
Operating profit (loss) 9901 €104,379 €148,190 +€43,811 +42.0%
Financial income 75/76B €4,081 €4,935 +€854 +20.9%
Recurring financial income 75 €4,081 €4,935 +€854 +20.9%
Financial charges 65/66B €5,053 €8,615 +€3,562 +70.5%
Recurring financial charges 65 €5,053 €8,615 +€3,562 +70.5%
Profit (loss) for the period before taxes 9903 €103,407 €144,511 +€41,104 +39.7%
Income taxes 67/77 €31,351 €43,719 +€12,368 +39.5%
Profit (loss) for the period 9904 €72,056 €100,792 +€28,736 +39.9%
Profit (loss) for the period to be appropriated 9905 €72,056 €100,792 +€28,736 +39.9%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 28 October 2026 via checked.be.